nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Hyperaesthesia—Epirubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Frovatriptan—Tinnitus—Sorafenib—thyroid cancer	0.00437	0.00437	CcSEcCtD
Frovatriptan—Flushing—Sorafenib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Frovatriptan—Dyspepsia—Vandetanib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Frovatriptan—Decreased appetite—Vandetanib—thyroid cancer	0.00429	0.00429	CcSEcCtD
Frovatriptan—Fatigue—Vandetanib—thyroid cancer	0.00426	0.00426	CcSEcCtD
Frovatriptan—Rigors—Epirubicin—thyroid cancer	0.00423	0.00423	CcSEcCtD
Frovatriptan—Pain—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Frovatriptan—Constipation—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Frovatriptan—Arrhythmia—Sorafenib—thyroid cancer	0.00419	0.00419	CcSEcCtD
Frovatriptan—Mental disorder—Sorafenib—thyroid cancer	0.00411	0.00411	CcSEcCtD
Frovatriptan—Malnutrition—Sorafenib—thyroid cancer	0.00408	0.00408	CcSEcCtD
Frovatriptan—Hyperaesthesia—Doxorubicin—thyroid cancer	0.00407	0.00407	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00404	0.00404	CcSEcCtD
Frovatriptan—Dysgeusia—Sorafenib—thyroid cancer	0.004	0.004	CcSEcCtD
Frovatriptan—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Frovatriptan—Muscle spasms—Sorafenib—thyroid cancer	0.00393	0.00393	CcSEcCtD
Frovatriptan—Rigors—Doxorubicin—thyroid cancer	0.00391	0.00391	CcSEcCtD
Frovatriptan—Abdominal pain—Vandetanib—thyroid cancer	0.00391	0.00391	CcSEcCtD
Frovatriptan—Body temperature increased—Vandetanib—thyroid cancer	0.00391	0.00391	CcSEcCtD
Frovatriptan—Arthropathy—Epirubicin—thyroid cancer	0.0038	0.0038	CcSEcCtD
Frovatriptan—Thinking abnormal—Epirubicin—thyroid cancer	0.00377	0.00377	CcSEcCtD
Frovatriptan—Hypocalcaemia—Epirubicin—thyroid cancer	0.00377	0.00377	CcSEcCtD
Frovatriptan—Nocturia—Epirubicin—thyroid cancer	0.00372	0.00372	CcSEcCtD
Frovatriptan—Syncope—Sorafenib—thyroid cancer	0.00366	0.00366	CcSEcCtD
Frovatriptan—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00364	0.00364	CcSEcCtD
Frovatriptan—Bone pain—Epirubicin—thyroid cancer	0.0036	0.0036	CcSEcCtD
Frovatriptan—Loss of consciousness—Sorafenib—thyroid cancer	0.00359	0.00359	CcSEcCtD
Frovatriptan—Asthenia—Vandetanib—thyroid cancer	0.00354	0.00354	CcSEcCtD
Frovatriptan—Gait disturbance—Epirubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Frovatriptan—Arthropathy—Doxorubicin—thyroid cancer	0.00351	0.00351	CcSEcCtD
Frovatriptan—Pruritus—Vandetanib—thyroid cancer	0.0035	0.0035	CcSEcCtD
Frovatriptan—Thinking abnormal—Doxorubicin—thyroid cancer	0.00349	0.00349	CcSEcCtD
Frovatriptan—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00349	0.00349	CcSEcCtD
Frovatriptan—Arthralgia—Sorafenib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Frovatriptan—Myalgia—Sorafenib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Frovatriptan—Hiccups—Epirubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Frovatriptan—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Frovatriptan—Nocturia—Doxorubicin—thyroid cancer	0.00344	0.00344	CcSEcCtD
Frovatriptan—Dry mouth—Sorafenib—thyroid cancer	0.0034	0.0034	CcSEcCtD
Frovatriptan—Eructation—Epirubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Frovatriptan—Diarrhoea—Vandetanib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Frovatriptan—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Frovatriptan—Bone pain—Doxorubicin—thyroid cancer	0.00333	0.00333	CcSEcCtD
Frovatriptan—Anaphylactic shock—Sorafenib—thyroid cancer	0.00333	0.00333	CcSEcCtD
Frovatriptan—Shock—Sorafenib—thyroid cancer	0.00328	0.00328	CcSEcCtD
Frovatriptan—Gait disturbance—Doxorubicin—thyroid cancer	0.00327	0.00327	CcSEcCtD
Frovatriptan—Dizziness—Vandetanib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Frovatriptan—Hiccups—Doxorubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Frovatriptan—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Frovatriptan—Anorexia—Sorafenib—thyroid cancer	0.00318	0.00318	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Frovatriptan—Vomiting—Vandetanib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Frovatriptan—Eructation—Doxorubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Frovatriptan—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Frovatriptan—Headache—Vandetanib—thyroid cancer	0.00309	0.00309	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00304	0.00304	CcSEcCtD
Frovatriptan—Hypertonia—Epirubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Frovatriptan—Abnormal vision—Epirubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Frovatriptan—Mental disability—Epirubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Frovatriptan—Dyspnoea—Sorafenib—thyroid cancer	0.00297	0.00297	CcSEcCtD
Frovatriptan—Nausea—Vandetanib—thyroid cancer	0.00293	0.00293	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00293	0.00293	CcSEcCtD
Frovatriptan—Dyspepsia—Sorafenib—thyroid cancer	0.00293	0.00293	CcSEcCtD
Frovatriptan—Decreased appetite—Sorafenib—thyroid cancer	0.0029	0.0029	CcSEcCtD
Frovatriptan—Fatigue—Sorafenib—thyroid cancer	0.00287	0.00287	CcSEcCtD
Frovatriptan—Pain—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Frovatriptan—Constipation—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Frovatriptan—Vascular purpura—Epirubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Frovatriptan—Hypertonia—Doxorubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Frovatriptan—Abnormal vision—Doxorubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Frovatriptan—Eye pain—Epirubicin—thyroid cancer	0.00278	0.00278	CcSEcCtD
Frovatriptan—Mental disability—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00273	0.00273	CcSEcCtD
Frovatriptan—Hot flush—Epirubicin—thyroid cancer	0.00268	0.00268	CcSEcCtD
Frovatriptan—Menopausal symptoms—Epirubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Frovatriptan—Body temperature increased—Sorafenib—thyroid cancer	0.00263	0.00263	CcSEcCtD
Frovatriptan—Abdominal pain—Sorafenib—thyroid cancer	0.00263	0.00263	CcSEcCtD
Frovatriptan—Dermatitis bullous—Epirubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Frovatriptan—Purpura—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Frovatriptan—Vascular purpura—Doxorubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Frovatriptan—Eye pain—Doxorubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Frovatriptan—Hypoglycaemia—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Frovatriptan—Osteoarthritis—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Frovatriptan—Pain in extremity—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Frovatriptan—Hot flush—Doxorubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Frovatriptan—Affect lability—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Frovatriptan—Migraine—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Frovatriptan—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Frovatriptan—Hypersensitivity—Sorafenib—thyroid cancer	0.00246	0.00246	CcSEcCtD
Frovatriptan—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Frovatriptan—Purpura—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Frovatriptan—Asthenia—Sorafenib—thyroid cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Frovatriptan—Mood swings—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Frovatriptan—Pruritus—Sorafenib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Frovatriptan—Ataxia—Epirubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Frovatriptan—Dehydration—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Frovatriptan—Osteoarthritis—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Frovatriptan—Pain in extremity—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Frovatriptan—Affect lability—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Frovatriptan—Migraine—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Frovatriptan—Diarrhoea—Sorafenib—thyroid cancer	0.00228	0.00228	CcSEcCtD
Frovatriptan—Muscular weakness—Epirubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Frovatriptan—Dizziness—Sorafenib—thyroid cancer	0.0022	0.0022	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Frovatriptan—Dysphagia—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Frovatriptan—Vomiting—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Frovatriptan—Headache—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Frovatriptan—Pollakiuria—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Frovatriptan—Nausea—Sorafenib—thyroid cancer	0.00198	0.00198	CcSEcCtD
Frovatriptan—Stomatitis—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Conjunctivitis—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Frovatriptan—Chills—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Frovatriptan—Tension—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Shock—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Pain—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—thyroid cancer	0.000991	0.000991	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—thyroid cancer	0.000982	0.000982	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—thyroid cancer	0.000939	0.000939	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000932	0.000932	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—thyroid cancer	0.000884	0.000884	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—thyroid cancer	0.000871	0.000871	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—thyroid cancer	0.00084	0.00084	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—thyroid cancer	0.000818	0.000818	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—thyroid cancer	0.000806	0.000806	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—thyroid cancer	0.000783	0.000783	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Frovatriptan—Headache—Epirubicin—thyroid cancer	0.000772	0.000772	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—thyroid cancer	0.000754	0.000754	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—thyroid cancer	0.000732	0.000732	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—thyroid cancer	0.000725	0.000725	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—thyroid cancer	0.000714	0.000714	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—thyroid cancer	0.000677	0.000677	CcSEcCtD
